Brief: UCB: New Data Supports Earlier Use Of Bimzelx For Treating Hidradenitis Suppurativa

UCB SA

30/09/2026 06:03

       Sept 30 (Reuters) - Ucb SA  UCB.BR :
    * NEW DATA AT EADV 2026 SUPPORTING EARLIER USE OF BIMZELX
(BIMEKIZUMAB) FOR TREATING HIDRADENITIS SUPPURATIVA
    * BIOLOGIC-NAIVE PATIENTS DEMONSTRATED IMPROVED DRAINING
TUNNEL OUTCOMES
    * IMPROVEMENTS BEYOND DRAINING TUNNELS TO TOTAL TUNNEL COUNT
    * ADDITIONAL LONG-TERM, THREE-YEAR DATA SHOWED TREATMENT IN
PEOPLE LIVING WITH MODERATE TO SEVERE HS ASSOCIATED WITH
SUSTAINED IMPROVEMENTS IN QUALITY OF LIFE

    Source text:  ID:nPLX217Q33 
    Further company coverage:  UCB.BR 

    (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))